Gordon Glazner - Publications

Affiliations: 
Pharmacology and Therapeutics University of Manitoba, Winnipeg, Manitoba, Canada 
Area:
Neuroscience Biology, Pharmacology

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Adlimoghaddam A, Odero GG, Glazner G, Turner RS, Albensi BC. Nilotinib Improves Bioenergetic Profiling in Brain Astroglia in the 3xTg Mouse Model of Alzheimer's Disease. Aging and Disease. 12: 441-465. PMID 33815876 DOI: 10.14336/AD.2020.0910  0.331
2020 Dar NJ, Glazner GW. Deciphering the neuroprotective and neurogenic potential of soluble amyloid precursor protein alpha (sAPPα). Cellular and Molecular Life Sciences : Cmls. PMID 31960113 DOI: 10.1007/S00018-019-03404-X  0.695
2015 Nafez S, Oikawa K, Odero GL, Sproule M, Ge N, Schapansky J, Abrenica B, Hatherell A, Cadonic C, Zhang S, Song X, Kauppinen T, Glazner GW, Grilli M, Czubryt MP, et al. Early growth response 2 (Egr-2) expression is triggered by NF-κB activation. Molecular and Cellular Neurosciences. 64: 95-103. PMID 25553923 DOI: 10.1016/J.Mcn.2014.12.008  0.707
2013 Saleh A, Schapansky J, Smith DR, Young N, Odero GL, Aulston B, Fernyhough P, Glazner GW. Normalization of NF-κB activity in dorsal root ganglia neurons cultured from diabetic rats reverses neuropathy-linked markers of cellular pathology. Experimental Neurology. 241: 169-78. PMID 23159890 DOI: 10.1016/J.Expneurol.2012.11.009  0.708
2010 Glazner KA, Odero GL, Anema E, Motnenko A, Schapansky J, Grossman D, Oliver DR, Glazner GW, Albensi BC. Strain specific differences in memory and neuropathology in a mouse model of Alzheimer's disease. Life Sciences. 86: 942-50. PMID 20470790 DOI: 10.1016/J.Lfs.2010.04.014  0.676
2010 Odero GL, Oikawa K, Glazner KA, Schapansky J, Grossman D, Thiessen JD, Motnenko A, Ge N, Martin M, Glazner GW, Albensi BC. Evidence for the involvement of calbindin D28k in the presenilin 1 model of Alzheimer's disease. Neuroscience. 169: 532-43. PMID 20399254 DOI: 10.1016/J.Neuroscience.2010.04.004  0.696
2009 Schapansky J, Morissette M, Odero G, Albensi B, Glazner G. Neuregulin beta1 enhances peak glutamate-induced intracellular calcium levels through endoplasmic reticulum calcium release in cultured hippocampal neurons. Canadian Journal of Physiology and Pharmacology. 87: 883-91. PMID 20052014 DOI: 10.1139/Y09-082  0.69
2007 Schapansky J, Olson K, Van Der Ploeg R, Glazner G. NF-kappaB activated by ER calcium release inhibits Abeta-mediated expression of CHOP protein: enhancement by AD-linked mutant presenilin 1. Experimental Neurology. 208: 169-76. PMID 17927985 DOI: 10.1016/J.Expneurol.2007.04.009  0.734
2005 Fernyhough P, Smith DR, Schapansky J, Van Der Ploeg R, Gardiner NJ, Tweed CW, Kontos A, Freeman L, Purves-Tyson TD, Glazner GW. Activation of nuclear factor-kappaB via endogenous tumor necrosis factor alpha regulates survival of axotomized adult sensory neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 1682-90. PMID 15716404 DOI: 10.1523/Jneurosci.3127-04.2005  0.723
2001 Glazner GW, Camandola S, Geiger JD, Mattson MP. Endoplasmic reticulum D-myo-inositol 1,4,5-trisphosphate-sensitive stores regulate nuclear factor-kappaB binding activity in a calcium-independent manner. The Journal of Biological Chemistry. 276: 22461-7. PMID 11309390 DOI: 10.1074/jbc.M101315200  0.42
2000 Glazner GW, Camandola S, Mattson MP. Nuclear factor-kappaB mediates the cell survival-promoting action of activity-dependent neurotrophic factor peptide-9. Journal of Neurochemistry. 75: 101-8. PMID 10854252 DOI: 10.1046/J.1471-4159.2000.0750101.X  0.411
2000 Glazner GW, Mattson MP. Differential effects of BDNF, ADNF9, and TNFalpha on levels of NMDA receptor subunits, calcium homeostasis, and neuronal vulnerability to excitotoxicity. Experimental Neurology. 161: 442-52. PMID 10686066 DOI: 10.1006/Exnr.1999.7242  0.354
1999 Guo Q, Sebastian L, Sopher BL, Miller MW, Glazner GW, Ware CB, Martin GM, Mattson MP. Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 mutation. Proceedings of the National Academy of Sciences of the United States of America. 96: 4125-30. PMID 10097174 DOI: 10.1073/Pnas.96.7.4125  0.369
Show low-probability matches.